Authors: Campone, M Fumoleau, P Delecroix, V Deporte-Fety, R Perrocheau, G Vernillet, L Borg-Olivier, O Louboutin, JP Bissery, MC Riva, A Azli, N

Citation: M. Campone et al., Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer, ANN ONCOL, 12(7), 2001, pp. 909-918

Authors: Nabholtz, JM Mackey, JR Smylie, M Paterson, A Noel, DR Al-Tweigeri, T Tonkin, K North, S Azli, N Riva, A

Citation: Jm. Nabholtz et al., Phase II study of docetaxel, doxorubicin, and cyclophosphamide as first-line chemotherapy for metastatic breast cancer, J CL ONCOL, 19(2), 2001, pp. 314-321

Authors: Khayat, D Chollet, P Antoine, EC Monfardini, S Ambrosini, G Benhammouda, A Mazen, MF Sorio, R Borg-Olivier, O Ramazeilles, C Azli, N

Citation: D. Khayat et al., Phase II study of sequential administration of docetaxel followed by doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breastcancer, J CL ONCOL, 19(14), 2001, pp. 3367-3375

Authors: Fandi, A Bachouchi, M Azli, N Taamma, A Boussen, H Wibault, P Eschwege, F Armand, JP Simon, J Cvitkovic, E

Citation: A. Fandi et al., Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type, J CL ONCOL, 18(6), 2000, pp. 1324-1330

Authors: Misset, JL Dieras, V Gruia, G Bourgeois, H Cvitkovic, E Kalla, S Bozec, L Beuzeboc, P Jasmin, C Aussel, JP Riva, A Azli, N Pouillart, P

Citation: Jl. Misset et al., Dose-finding study of docetaxel and doxorubicin in first-line treatment ofpatients with metastatic breast cancer, ANN ONCOL, 10(5), 1999, pp. 553-560

Authors: Taamma, A Fandi, A Azli, N Wibault, P Chouaki, N Hasbini, A Couteau, C Armand, JP Cvitkovic, E

Citation: A. Taamma et al., Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin,and cisplatin for patients with locally advanced, metastatic, or recurrentundifferentiated carcinoma of the nasopharyngeal type, CANCER, 86(7), 1999, pp. 1101-1108